The group's principal activities are to develop, manufacture and market a proprietary excimer laser system for the removal of tissue, specifically addressing multiple cardiovascular disorders. The group's products include cvx-300-laser unit, disposable laser devices and vitesse-tm-laser catheter. The cvx-300-laser unit is a proprietary excimer laser designed specifically for use in cardiovascular applications. The disposable laser devices is an integral part of the excimer laser system. The group markets in Canada, Mexico, South America, the Pacific Rim and Australia.
